×
About 32,775 results

ALLMedicine™ Colon Cancer Center

Research & Reviews  10,458 results

BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability i...
https://doi.org/10.1002/cam4.4954
Cancer Medicine; Zhu Q, Gu X et. al.

Jul 3rd, 2022 - The intensive interplay between aberrant epigenetic events and metabolic remodeling represents one of the hallmarks of tumors, including colon cancer. The functions of Bromodomain Containing Protein BRD-9 in colon cancer remains indefinite. We aim...

Proton Pump Inhibitor Use and Obesity-Associated Cancers in the Women's Health Initiative.
https://doi.org/10.1158/1055-9965.EPI-22-0475
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Ballinger TJ, Djuric Z et. al.

Jul 2nd, 2022 - Proton pump inhibitors (PPIs) inhibit fatty acid synthase (FAS), a critical enzyme in lipogenesis, energy balance, and cancer cell survival. We aimed to evaluate the association of PPI use with incidence of common obesity- related cancers in women...

Evaluating the value of tumor length times width in colorectal adenocarcinoma with diff...
https://doi.org/10.1097/MD.0000000000029845
Medicine Zhou E, Chen J et. al.

Jul 2nd, 2022 - The T classification, which reflects the vertical growth pattern of the tumor, is one of the most important prognostic factors in colorectal cancer. We aimed to investigate the prognostic value of tumor length and width in patients with colorectal...

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
https://clinicaltrials.gov/ct2/show/NCT01851369

Jul 1st, 2022 - Background: -Base excision repair (BER) of DNA repair pathway has been implicated in resistance to both alkylating and antimetabolite chemotherapy. -TRC102 (methoxyamine HCl) acts through a novel mechanism to inhibit BER and has demonstrated the a...

Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance
https://clinicaltrials.gov/ct2/show/NCT02767986

Jul 1st, 2022 - Research to understand the sources of health disparities has acknowledged that in addition to biomedical risk factors, culture plays an important role in differential health outcomes. Consequently, understanding cultural differences that may influ...

see more →

Guidelines  29 results

ACR Appropriateness Criteria® Staging of Colorectal Cancer: 2021 Update.
https://doi.org/10.1016/j.jacr.2022.02.012
Journal of the American College of Radiology : JACR; , Korngold EK et. al.

May 14th, 2022 - Preoperative imaging of rectal carcinoma involves accurate assessment of the primary tumor as well as distant metastatic disease. Preoperative imaging of nonrectal colon cancer is most beneficial in identifying distant metastases, regardless of pr...

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the ...
https://doi.org/10.1097/DCR.0000000000002323
Diseases of the Colon and Rectum; Vogel JD, Felder SI et. al.

Nov 15th, 2021 - The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer.|2021|Vogel JD,Felder SI,Bhama AR,Hawkins AT,Langenfeld SJ,|diagnosis,etiology,therapy,

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and fol...
https://doi.org/10.1016/j.annonc.2021.08.1752
Annals of Oncology : Official Journal of the European Soc... Yoshino T, Argilés G et. al.

Aug 20th, 2021 - The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of localised colon cancer was published in 2020. It was decided by both the ESMO and the Japanese S...

Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
https://doi.org/10.1016/j.clinre.2021.101775
Clinics and Research in Hepatology and Gastroenterology; Chazouillères O, Potier P et. al.

Aug 1st, 2021 - Primary sclerosing cholangitis (PSC) is a rare and chronic cholestatic liver disease of unknown cause commonly associated with inflammatory bowel disease (IBD) and characterized by progressive obliterative fibro-inflammation of the biliary tree. A...

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2021.0012
Journal of the National Comprehensive Cancer Network : JN... Benson AB, Venook AP et. al.

Mar 17th, 2021 - This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been mad...

see more →

Drugs  70 results see all →

Clinicaltrials.gov  930 results

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
https://clinicaltrials.gov/ct2/show/NCT01851369

Jul 1st, 2022 - Background: -Base excision repair (BER) of DNA repair pathway has been implicated in resistance to both alkylating and antimetabolite chemotherapy. -TRC102 (methoxyamine HCl) acts through a novel mechanism to inhibit BER and has demonstrated the a...

Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance
https://clinicaltrials.gov/ct2/show/NCT02767986

Jul 1st, 2022 - Research to understand the sources of health disparities has acknowledged that in addition to biomedical risk factors, culture plays an important role in differential health outcomes. Consequently, understanding cultural differences that may influ...

Rural Colon Cancer Screening Toolkit Intervention
https://clinicaltrials.gov/ct2/show/NCT04651504

Jul 1st, 2022 - Less than half of all positive fecal immunochemical testing (FIT)s are followed-up by colonoscopy, thus limiting the full potential of colorectal cancer (CRC) screening to reduce mortality. Given the need for coordination in order to achieve high ...

Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
https://clinicaltrials.gov/ct2/show/NCT04708470

Jul 1st, 2022 - Background: Although PD-1(L1) inhibitors have been approved for the treatment of over a dozen different tumor types in recent years, the majority of patients with advanced cancer still do not respond to these agents, including patients with micros...

Risk Communication Within Mexican-American Families
https://clinicaltrials.gov/ct2/show/NCT00469339

Jul 1st, 2022 - The current project aims to understand the mechanisms underlying communications about familial risk for common, complex diseases and the development of strategies by Mexican American families to address this risk. For the Mexican American communit...

see more →

News  1,581 results

‘The Rock’ assumes the presidency of AGA
https://www.mdedge.com/gihepnews/article/255939/society-news/rock-assumes-presidency-aga

Jun 30th, 2022 - We’re honored to announce that John M. Carethers, MD, AGAF, affectionately nicknamed ‘The Rock,’ will begin his term as the 117th president of the AGA Institute on June 1, 2022.

My picks for best of ASCO 2022
https://www.mdedge.com/hematology-oncology/article/255805/asco-lung-cancer/my-picks-best-asco-2022
David H. Henry, MD

Jun 28th, 2022 - CHICAGO – The American Society of Clinical Oncology recently wrapped its annual meeting in Chicago. Many of us attended virtually, or in person, and were wowed by some of the abstracts and their implications for our patients – some practice changi.

Multi-agent vs. single-agent adjuvant chemotherapy in elderly patients with stage III colon cancer
https://www.mdedge.com/hematology-oncology/article/255628/gastrointestinal-cancer/multi-agent-vs-single-agent-adjuvant

Jun 22nd, 2022 - Key clinical point: Multi-agent adjuvant chemotherapy (MAC) offers a survival benefit over single-agent adjuvant chemotherapy (SAC) in patients with stage III colon cancer (CC) aged 70-75 years, but not for older patients. Major finding: MAC vs.

Multi-agent vs. single-agent adjuvant chemotherapy in elderly patients with stage III colon cancer
https://www.mdedge.com/hematology-oncology/article/255627/gastrointestinal-cancer/multi-agent-vs-single-agent-adjuvant

Jun 22nd, 2022 - Key clinical point: Multi-agent adjuvant chemotherapy (MAC) offers a survival benefit over single-agent adjuvant chemotherapy (SAC) in patients with stage III colon cancer (CC) aged 70-75 years, but not for older patients. Major finding: MAC vs.

AI-based CADe outperforms high-definition white light in colonoscopy
https://www.mdedge.com/hematology-oncology/article/255382/gastrointestinal-cancer/ai-based-cade-outperforms-high-definition
Brandon May

Jun 13th, 2022 - An artificial intelligence (AI)–based computer-aided polyp detection (CADe) system missed fewer adenomas, polyps, and sessile serrated lesions and identified more adenomas per colonoscopy than a high-definition white light (HDWL) colonoscopy, acco.

see more →

Patient Education  42 results see all →